The DOI matches its Crossref record; 501 of the 514 references it cites were found in a registry or an index.
Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease
Open accessAbstract
Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-inducible expression of a battery of genes encoding key components of the glutathione-based and thioredoxin-based antioxidant systems, as well as aldo-keto reductase, glutathione S-transferase, and Nad(p)h quinone oxidoreductase-1 drug-metabolizing isoenzymes along with multidrug-resistance-associated efflux pumps. It therefore plays a pivotal role in both intrinsic resistance and cellular adaptation to reactive oxygen species (ROS) and xenobiotics. Activation of Nrf2 can, however, serve as a double-edged sword because some of the genes it induces may contribute to chemical carcinogenesis by promoting futile redox cycling of polycyclic aromatic hydrocarbon metabolites or confer resistance to chemotherapeutic drugs by increasing the expression of efflux pumps, suggesting its cytoprotective effects will vary in a context-specific fashion. In addition to cytoprotection, Nrf2 also controls genes involved in intermediary metabolism, positively regulating those involved in NADPH generation, purine biosynthesis, and the β-oxidation of fatty acids, while suppressing those involved in lipogenesis and gluconeogenesis. Nrf2 is subject to regulation at multiple levels. Its ability to orchestrate adaptation to oxidants and electrophiles is due principally to stress-stimulated modification of thiols within one of its repressors, the Kelch-like ECH-associated protein 1 (Keap1), which is present in the cullin-3 RING ubiquitin ligase (CRL) complex CRLKeap1. Thus modification of Cys residues in Keap1 blocks CRLKeap1 activity, allowing newly translated Nrf2 to accumulate rapidly and induce its target genes. The ability of Keap1 to repress Nrf2 can be attenuated by p62/sequestosome-1 in a mechanistic target of rapamycin complex 1 (mTORC1)-dependent manner, thereby allowing refeeding after fasting to increase Nrf2-target gene expression. In parallel with repression by Keap1, Nrf2 is also repressed by β-transducin repeat-containing protein (β-TrCP), present in the Skp1-cullin-1-F-box protein (SCF) ubiquitin ligase complex SCFβ-TrCP. The ability of SCFβ-TrCP to suppress Nrf2 activity is itself enhanced by prior phosphorylation of the transcription factor by glycogen synthase kinase-3 (GSK-3) through formation of a DSGIS-containing phosphodegron. However, formation of the phosphodegron in Nrf2 by GSK-3 is inhibited by stimuli that activate protein kinase B (PKB)/Akt. In particular, PKB/Akt activity can be increased by phosphoinositide 3-kinase and mTORC2, thereby providing an explanation of why antioxidant-responsive element-driven genes are induced by growth factors and nutrients. Thus Nrf2 activity is tightly controlled via CRLKeap1 and SCFβ-TrCP by oxidative stress and energy-based signals, allowing it to mediate adaptive responses that restore redox homeostasis and modulate intermediary metabolism. Based on the fact that Nrf2 influences multiple biochemical pathways in both positive and negative ways, it is likely its dose-response curve, in terms of susceptibility to certain degenerative disease, is U-shaped. Specifically, too little Nrf2 activity will lead to loss of cytoprotection, diminished antioxidant capacity, and lowered β-oxidation of fatty acids, while conversely also exhibiting heightened sensitivity to ROS-based signaling that involves receptor tyrosine kinases and apoptosis signal-regulating kinase-1. By contrast, too much Nrf2 activity disturbs the homeostatic balance in favor of reduction, and so may have deleterious consequences including overproduction of reduced glutathione and NADPH, the blunting of ROS-based signal transduction, epithelial cell hyperplasia, and failure of certain cell types to differentiate correctly. We discuss the basis of a putative U-shaped Nrf2 dose-response curve in terms of potentially competing processes relevant to different stages of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This interaction is mediated by a 349DPSTGE354 motif in p62’s Keap1-interacting region (KIR) that resembles the ETGE motif in the Keap1-binding domain of Nrf2 [79,80,81].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [79]
In the citing paper
“In response to elevated levels of reactive oxygen species (ROS) and environmental toxins or to nutrient and metabolic changes through mTOR signaling and insulin/IGF signaling, NRF/SKN-1 activates the expression of genes involved in cellular protection (Blackwell et al., 2015; Tebay et al., 2015).”
From The Aging Epigenome (2016) · cites this paper as Tebay et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 501
Xu, C., Huang, M., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 379
Rhee, S. G., Yang, K.-S., Kang, S. W., Woo, H. A., & Chang, T.-S. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.619 · Cited by 376
Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila
Hochmuth, C. E., Biteau, B., Bohmann, D., & Jasper, H. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.006 · Cited by 374
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 372
Singh, A., Boldin‐Adamsky, S., Thimmulappa, R. K., Rath, S. K., Ashush, H., Coulter, J. B., Blackford, A. L., Goodman, S. N., Bunz, F., Watson, W. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1401 · Cited by 371
Beneficial role of Nrf2 in regulating NADPH generation and consumption
Wu, K. C., Cui, J. Y., & Klaassen, C. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr183 · Cited by 368
Nioi, P., & Hayes, J. D. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.05.023 · Cited by 364
Self-citationTobiume, K., Saitoh, M., & Ichijo, H. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10080 · Cited by 362
ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity
Colicelli, J. (2010) · Science Signaling · doi:10.1126/scisignal.3139re6 · Cited by 357
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
Kim, Y. R., Oh, J. E., Kim, M. S., Kang, M. R., Park, S. W., Han, J. Y., Eom, H., Yoo, N. J., & Lee, S. H. (2009) · The Journal of Pathology · doi:10.1002/path.2653 · Cited by 357
Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosisPreprint
Wu, T., Zhao, F. L., Gao, B., Tan, C., Yagishita, N., Nakajima, T., Wong, P. K., Chapman, E., Fang, D., & Zhang, D. D. (2014) · Genes & Development · doi:10.1101/gad.238246.114 · Cited by 355
NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis
Shin, S., Wakabayashi, N., Misra, V., Biswal, S., Lee, G., Agoston, E., Yamamoto, M., & Kensler, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00915-07 · Cited by 355
The GI-GPx Gene Is a Target for Nrf2
Banning, A., Deubel, S., Kluth�, D., Zhou, Z., & Brigelius‐Flohé, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4914-4923.2005 · Cited by 344
Identification of the interactive interface and phylogenic conservation of the Nrf2‐Keap1 system
Kobayashi, M., Itoh, K., Suzuki, T., Osanai, H., Nishikawa, K., Katoh, Y., Takagi, Y., & Yamamoto, M. P. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00561.x · Cited by 340
Marzec, J. M., Christie, J. D., Reddy, S. P., Jedlicka, A., Vuong, H., Lanken, P. N., Aplenc, R., Yamamoto, T., Yamamoto, M. P., Cho, H., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7759com · Cited by 340
ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function
Pi, J., Zhang, Q., Fu, J., Woods, C. G., Hou, Y., Corkey, B. E., Collins, S., & Andersen, M. E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.05.025 · Cited by 340
The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T. W., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00225-13 · Cited by 339
Benson, A. M., Batzinger, R. P., Ou, S.-Y. L., Bueding, E., Cha, Y., & Talalay, P. (1978) · PubMed · Cited by 337
Wu, G., Xu, G., Schulman, B. A., Jeffrey, P. D., Harper, J. W., & Pavletich, N. P. (2003) · Molecules and Cells · Cited by 333
Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
Singh, A., Happel, C., Manna, S. K., Acquaah-Mensah, G., Carrerero, J., Kumar, S., Nasipuri, P., Krausz, K. W., Wakabayashi, N., Dewi, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66353 · Cited by 333
Jaźwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández‐Ruíz, J., & Cuadrado, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 329
Protein kinase D mediates a stress‐induced NF‐κB activation and survival pathway
Störz, P., & Toker, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdg009 · Cited by 325
Hayes, J. D., Chanas, S. A., Henderson, C. J., McMahon, M. J., Sun, C., Moffat, G. J., Wolf, C. R., & Yamamoto, M. P. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280033 · Cited by 321
Self-citationMaher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G. L., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21831 · Cited by 319
Numazawa, S., Ishikawa, M., Yoshida, A., Tanaka, S., & Yoshida, T. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2003 · Cited by 319
Ero1 and redox homeostasis in the endoplasmic reticulum
Sevier, C. S., & Kaiser, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.12.011 · Cited by 315
Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation
Hyeon, S., Lee, H., Yang, Y., & Jeong, W. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.005 · Cited by 313
Wang, X. J., Hayes, J. D., Henderson, C. J., & Wolf, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709483104 · Cited by 310
Self-citationTargeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 306
MacLeod, A. K., McMahon, M. J., Plummer, S. M., Higgins, L. G., Penning, T. M., Igarashi, K., & Hayes, J. D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp176 · Cited by 305
Self-citationTwo tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene
Mignotte, V., Wall, L., de Boer, E., Grosveld, F. G., & Roméo, P. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.1.37 · Cited by 302
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
Lo, S.-C., & Hannink, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.014 · Cited by 300
Kobayashi, A., Ito, E., Toki, T., Kogame, K., Takahashi, S., Igarashi, K., Hayashi, N., & Yamamoto, M. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6443 · Cited by 299
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Tao, S., Wang, S., Moghaddam, S. J., Ooi, A., Chapman, E., Wong, P. K., & Zhang, D. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1439 · Cited by 291
Rushworth, S. A., Zaitseva, L., Murray, M. Y., Shah, N. M., Bowles, K. M., & MacEwan, D. J. (2012) · Blood · doi:10.1182/blood-2012-04-422121 · Cited by 290
Paul, M. K., Bisht, B., Darmawan, D. O., Chiou, R., Ha, V. L., Wallace, W. D., Chon, A. T., Hegab, A. E., Grogan, T., Elashoff, D. A., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.009 · Cited by 289
Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J. D., & Yamamoto, M. P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8044-8051.2005 · Cited by 289
Xu, Z., Chen, L., Leung, L., Yen, T. S. B., Lee, C., & Chan, J. Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500660102 · Cited by 288
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
Jiang, T., Chen, N., Zhao, F., Wang, X.-J., Kong, B., Zheng, W., & Zhang, D. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0713 · Cited by 286
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Takaya, K., Suzuki, T., Motohashi, H., Onodera, K., Satomi, S., Kensler, T. W., & Yamamoto, M. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.023 · Cited by 284
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
Canning, P., Cooper, C. D. O., Krojer, T., Murray, J. W., Pike, A. C. W., Chaikuad, A., Keates, T., Thangaratnarajah, C., Hojzan, V., Marsden, B. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437996 · Cited by 284 · cited 5×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript protein-protein interaction domain; an intervening region (IVR); a C-terminal doubleglycine repeat (DGR) domain (that consists of six subdomains, each of which contains a distinctive Gly-Gly motif, and is sometimes called the Kelch-repeat…”
InfluentialAMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Molecular mechanisms of drug resistance
Hayes, J. D., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2720281 · Cited by 279
Self-citationChan, J. Y., Kwong, M., Lu, R., Chang, J., Wang, B., Yen, T. S. B., & Kan, Y. W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1779 · Cited by 277
Cell Signaling through Protein Kinase C Oxidation and Activation
Cosentino‐Gomes, D., Rocco-Machado, N., & Meyer‐Fernandes, J. R. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130910697 · Cited by 276
Shin, S., Wakabayashi, J., Yates, M. S., Wakabayashi, N., Dolan, P. M., Aja, S. M., Liby, K. T., Sporn, M. B., Yamamoto, M. P., & Kensler, T. W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.022 · Cited by 275
Bai, Y., Cui, W., Xin, Y., Miao, X., Barati, M. T., Zhang, C., Chen, Q., Tan, Y., Cui, T., Zheng, Y., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.01.008 · Cited by 274
Meng, T., Buckley, D. A., Galić, S., Tiganis, T., & Tonks, N. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404606200 · Cited by 274
Yates, M. S., Tran, Q. T., Dolan, P. M., Osburn, W. O., Shin, S., McCulloch, C. C., Silkworth, J. B., Taguchi, K., Yamamoto, M. P., Williams, C. R., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp100 · Cited by 272
Woo, S. Y., Kim, J. H., Moon, M. K., Han, S. H., Yeon, S. K., Choi, J., Jang, B. K., Song, H. J., Kang, Y. G., Kim, J. W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401788m · Cited by 270
Konishi, H., Yamauchi, E., Taniguchi, H., Yamamoto, T., Matsuzaki, H., Takemura, Y., Ohmae, K., Kikkawa, U., & Nishizuka, Y. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.111158798 · Cited by 269
Wen, S.-T., & Etten, R. A. V. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 267
Fukutomi, T., Takagi, K., Mizushima, T., Ohuchi, N., & Yamamoto, M. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01191-13 · Cited by 267
Thioredoxin signaling as a target for cancer therapy
Powis, G., & Kirkpatrick, D. L. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.003 · Cited by 265
Fujino, G., Noguchi, T., Matsuzawa, A., Yamauchi, S., Saitoh, M., Takeda, K., & Ichijo, H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00227-07 · Cited by 262
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
Chowdhry, S., Nazmy, M., Meakin, P. J., Dinkova‐Kostova, A. T., Walsh, S. V., Tsujita, T., Dillon, J. F., Ashford, M. L. J., & Hayes, J. D. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.007 · Cited by 260
Self-citationDinkova‐Kostova, A. T., & Talalay, P. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00300-2 · Cited by 259
Self-citationAgyeman, A. S., Chaerkady, R., Shaw, P. G., Davidson, N. E., Visvanathan, K., Pandey, A., & Kensler, T. W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1536-9 · Cited by 256
Reactive oxygen species and insulin resistance: the good, the bad and the ugly
Tiganis, T. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.006 · Cited by 256
Satoh, H., Moriguchi, T., Takai, J., Ebina, M., & Yamamoto, M. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4499 · Cited by 254
Nrf2-mediated protection against 6-hydroxydopamine
Jakel, R. J., Townsend, J. A., Kraft, A. D., & Johnson, J. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.131 · Cited by 252
Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes
He, X., Kan, H. J., Cai, L., & Ma, Q. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.007 · Cited by 250
Regulation of Nrf2 signaling and longevity in naturally long-lived rodents
Lewis, K. N., Wason, E., Edrey, Y. H., Kristan, D. M., Nevo, E., & Buffenstein, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417566112 · Cited by 249
Nrf2, a Guardian of Healthspan and Gatekeeper of Species Longevity
Lewis, K. N., Mele, J., Hayes, J. D., & Buffenstein, R. (2010) · Integrative and Comparative Biology · doi:10.1093/icb/icq034 · Cited by 249
Self-citationSingh, A., Rangasamy, T., Thimmulappa, R. K., Lee, H., Osburn, W. O., Brigelius‐Flohé, R., Kensler, T. W., Yamamoto, M. P., & Biswal, S. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0325oc · Cited by 248
Emerging and diverse roles of protein kinase C in immune cell signalling
Tan, S., & Parker, P. J. (2003) · Biochemical Journal · doi:10.1042/bj20031406 · Cited by 247
The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases
Gururaj Joshi, A., & Johnson, J. A. (2012) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912803252023 · Cited by 246
Apoptosis Signal-Regulating Kinase 1 in Stress and Immune Response
Takeda, K., Noguchi, T., Naguro, I., & Ichijo, H. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094606 · Cited by 244
Sevier, C. S., Qu, H., Heldman, N., Gross, E., Fass, D., & Kaiser, C. A. (2007) · Cell · doi:10.1016/j.cell.2007.02.039 · Cited by 242
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation
Ludtmann, M. H. R., Angelova, P. R., Zhang, Y., Abramov, A. Y., & Dinkova‐Kostova, A. T. (2013) · Biochemical Journal · doi:10.1042/bj20130863 · Cited by 241
Self-citationHourihan, J. M., Kenna, J. G., & Hayes, J. D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4944 · Cited by 239
Self-citationLeveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies
Ladewig, J., Koch, P., & Brüstle, O. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3543 · Cited by 236
The rise of antioxidant signaling—The evolution and hormetic actions of Nrf2
Maher, J. M., & Yamamoto, M. P. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.01.011 · Cited by 235
Nrf2 Amplifies Oxidative Stress via Induction of Klf9
Zucker, S. N., Fink, E. E., Bagati, A., Mannava, S., Bianchi, A., Bogner, P. N., Wawrzyniak, J. A., Foley, C. E., Leonova, K. I., Grimm, M. J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.01.033 · Cited by 234
Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice
Cho, H., Gladwell, W., Wang, X., Chorley, B. N., Bell, D. A., Reddy, S. P., & Kleeberger, S. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1047oc · Cited by 233
Meakin, P. J., Chowdhry, S., Sharma, R. S., Ashford, F. B., Walsh, S. V., McCrimmon, R. J., Dinkova‐Kostova, A. T., Dillon, J. F., Hayes, J. D., & Ashford, M. L. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00677-14 · Cited by 233
Self-citationOgura, T., Tong, K. I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C., & Yamamoto, M. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914036107 · Cited by 232
Arsenic Inhibits Autophagic Flux, Activating the Nrf2-Keap1 Pathway in a p62-Dependent Manner
Lau, A., Zheng, Y., Tao, S., Wang, H., Whitman, S. A., White, E., & Zhang, D. D. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01748-12 · Cited by 231
Dinkova‐Kostova, A. T., Jenkins, S. N., Fahey, J. W., Ye, L., Wehage, S. L., Liby, K. T., Stephenson, K. K., Wade, K. L., & Talalay, P. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.09.012 · Cited by 230
Self-citationFriling, R. S., Bergelson, S., & Daniel, V. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.668 · Cited by 229
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 227
Störz, P., Döppler, H. R., & Toker, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2614-2626.2004 · Cited by 227
Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T., et al. (2011) · Neoplasia · doi:10.1593/neo.11750 · Cited by 224
Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration
Wakabayashi, N., Shin, S., Slocum, S. L., Agoston, E. S., Wakabayashi, J., Kwak, M.-K., Misra, V., Biswal, S. S., Yamamoto, M. P., & Kensler, T. W. (2010) · Science Signaling · doi:10.1126/scisignal.2000762 · Cited by 224
Ionizing Radiation Activates the Nrf2 Antioxidant Response
McDonald, J., Kim, K., Norris, A. J., Vlashi, E., Phillips, T. M., Lagadec, C. H., Donna, L. D., Ratikan, J. A., Szelag, H., Hlatky, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0171 · Cited by 224
Palackal, N. T., Lee, S. H., Harvey, R. G., Blair, I. A., & Penning, T. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112424200 · Cited by 223
Self-citationMa, Q., Kinneer, K., Bi, Y., Chan, J. Y., & Kan, Y. W. (2004) · Biochemical Journal · doi:10.1042/bj20031123 · Cited by 220
Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin
Jaiswal, A. K. (1991) · Biochemistry · doi:10.1021/bi00108a007 · Cited by 219
Nrf2: control of sensitivity to carcinogens
Slocum, S. L., & Kensler, T. W. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0675-4 · Cited by 219
Katoh, Y., Iida, K., Kang, M.-I., Kobayashi, A., Mizukami, M., Tong, K. I., McMahon, M. J., Hayes, J. D., Itoh, K., & Yamamoto, M. P. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.10.012 · Cited by 217
Self-citationHiggins, L. G., & Hayes, J. D. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.567391 · Cited by 217
Self-citationProtein-DNA Interactions at Recognition Sites for the Dioxin-Ah Receptor Complex
Denison, M. S., Fisher, J. M., & Whitlock, J. P. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84730-0 · Cited by 216
Somatic mutations of the KEAP1 gene in common solid cancers
Yoo, N. J., Kim, H. R., Kim, Y. R., An, C. H., & Lee, S. H. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04178.x · Cited by 216
NRF2 plays a protective role in diabetic retinopathy in mice
Xu, Z., Wei, Y., Gong, J., Cho, H., Park, J. K., Sung, E.-R., Hu, H., Wu, L., Eberhart, C. G., Handa, J. T., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3093-8 · Cited by 214
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Johnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp274 · Cited by 210
Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A., Takeuchi, M., Yamagishi, S., Morito, N., Nakano, T., Ojima, M., Shimohata, H., et al. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01234.x · Cited by 207
An Auto-regulatory Loop between Stress Sensors INrf2 and Nrf2 Controls Their Cellular Abundance
Lee, O.-H., Jain, A. K., Papusha, V. Z., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706517200 · Cited by 205
Jang, J., Wang, Y., Kim, H.-S., Lalli, M. A., & Kosik, K. S. (2014) · Stem Cells · doi:10.1002/stem.1764 · Cited by 203
Nrf2 regulates haematopoietic stem cell function
Tsai, J. J.-Y., Dudakov, J. A., Takahashi, K., Shieh, J.-H., Velardi, E., Holland, A. M., Singer, N. V., West, M. L., Smith, O. M., Young, L. F., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2699 · Cited by 202
Ramos‐Gómez, M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.461 · Cited by 200
Redox Regulation of Epidermal Growth Factor Receptor Signaling through Cysteine Oxidation
Truong, T. H., & Carroll, K. S. (2012) · Biochemistry · doi:10.1021/bi301441e · Cited by 199
Lo, S.-C., & Hannink, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606539200 · Cited by 199 · cited 1×
“Phosphoglycerate mutase 5 (PGAM5) may also be degraded in a Keap1-dependent fashion [282], as may inhibitor of κB kinase β (IKKβ) [283, 284].”
Gao, X., Dinkova‐Kostova, A. T., & Talalay, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261572998 · Cited by 198
Self-citationThe Capable ABL: What Is Its Biological Function?
Wang, J. Y. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01454-13 · Cited by 197
Lin, H.-K., Jez, J. M., Schlegel, B. P., Peehl, D. M., Pachter, J. A., & Penning, T. M. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.13.0026 · Cited by 194
Self-citationLi, J., Lee, J., & Johnson, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109380200 · Cited by 193
Tanito, M., Masutani, H., Kim, Y., Nishikawa, M., Ohira, A., & Yodoi, J. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-1120 · Cited by 192
Bell, K. F. S., Al-Mubarak, B., Martel, M.-A., McKay, S., Wheelan, N., Hasel, P., Márkus, N. M., Baxter, P., Deighton, R. F., Serio, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms8066 · Cited by 191
Self-citationBurczynski, M. E., Gopishetty, S. R., Palackal, N. T., & Penning, T. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006655200 · Cited by 191
Self-citationYates, M. S., Kwak, M.-K., Egner, P. A., Groopman, J. D., Bodreddigari, S., Sutter, T. R., Baumgartner, K. J., Roebuck, B. D., Liby, K. T., Yore, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3823 · Cited by 191
Burczynski, M. E., Hseuh-Kung, L. I. N., & Penning, T. M. (1999) · PubMed · Cited by 189
Self-citationIn vivo modulation of the Parkinsonian phenotype by Nrf2
Burton, N. C., Kensler, T. W., & Guilarte, T. R. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.019 · Cited by 187
Xu, J., Kulkarni, S. R., Donepudi, A. C., More, V. R., & Slitt, A. L. (2012) · Diabetes · doi:10.2337/db11-1716 · Cited by 187
Hayes, J. D., Chowdhry, S., Dinkova‐Kostova, A. T., & Sutherland, C. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150011 · Cited by 187
Self-citationNrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice
Chartoumpekis, D. V., Ziros, P. G., Psyrogiannis, A. I., Papavassiliou, A. G., Kyriazopoulou, V. E., Sykiotis, G. P., & Habeos, I. G. (2011) · Diabetes · doi:10.2337/db11-0112 · Cited by 186
Mitochondrial SKN-1/Nrf Mediates a Conserved Starvation Response
Paek, J., Lo, J. Y., Narasimhan, S. D., Nguyen, T. N., Glover-Cutter, K. M., Robida-Stubbs, S., Suzuki, T., Yamamoto, M. P., Blackwell, T. K., & Curran, S. P. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.007 · Cited by 183
Cheng, X., Siow, R. C. M., & Mann, G. E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3283 · Cited by 182
Sussan, T. E., Jun, J. C., Thimmulappa, R. K., Bedja, D., Antero, M. F., Gabrielson, K. L., Polotsky, V. Y., & Biswal, S. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003791 · Cited by 182
Seo, J. H., Ahn, Y., Lee, S.-R., Yeo, C., & Hur, K. C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-05-0369 · Cited by 181
Global proteomic assessment of the classical protein-tyrosine phosphatome and “Redoxome”
Karisch, R., Fernandez, M., Taylor, P., Virtanen, C., St-Germain, J. R., Jin, L. L., Harris, I. S., Mori, J., Mak, T. W., Senis, Y. A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.020 · Cited by 179
Mechanism of Chemical Activation of Nrf2
Li, Y., Paonessa, J. D., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035122 · Cited by 179
Higgins, L. G., Kelleher, M., Eggleston, I. M., Itoh, K., Yamamoto, M. P., & Hayes, J. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.005 · Cited by 178
Self-citationWattenberg, L. W. (1996) · Preventive Medicine · doi:10.1006/pmed.1996.0015 · Cited by 177
Carlson, B. A., Novoselov, S. V., Kumaraswamy, E., Lee, B. J., Anver, M. R., Gladyshev, V. N., & Hatfield, D. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310470200 · Cited by 177
Chakravarthi, S., & Bulleid, N. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406912200 · Cited by 176
Yang, L., Calingasan, N. Y., Thomas, B., Chaturvedi, R. K., Kiaei, M., Wille, E. J., Liby, K. T., Williams, C. R., Royce, D. B., Risingsong, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005757 · Cited by 173
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
Aleyasin, H., Rousseaux, M. W. C., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., Parsanejad, M., Kim, R. H., Rizzu, P., Callaghan, S. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914876107 · Cited by 173
Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M. P., Kensler, T. W., Ratan, R. R., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4491 · Cited by 172
Kitteringham, N. R., Abdullah, A., Walsh, J., Randle, L. E., Jenkins, R. E., Sison-Young, R. L. C., Goldring, C. E., Powell, H., Sanderson, C. M., Williams, S. J., et al. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.03.018 · Cited by 172
Self-citationMatsuura, K., Shiraishi, H., Hara, A., Sato, K., Deyashiki, Y., Ninomiya, M., & Sakai, S. (1998) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022211 · Cited by 172
Selenius, M., Rundlöf, A.-K., Olm, E., Fernandes, A. P., & Björnstedt, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2884 · Cited by 170
Zhang, Y.-K. J., Yeager, R. L., Tanaka, Y., & Klaassen, C. D. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.03.016 · Cited by 170
Inhibition of Chemical Carcinogen-Induced Pulmonary Neoplasia by Butylated Hydroxyanisole
Wattenberg, L. W. (1973) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/50.6.1541 · Cited by 166
Burczynski, M. E., & Penning, T. M. (2000) · PubMed · Cited by 165
Self-citationLee, D.-H., Gold, R., & Linker, R. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911783 · Cited by 163
Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., Taguchi, K., Yanagawa, T., Nakahara, A., Hyodo, I., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00296.2009 · Cited by 163
Ooi, A., Dykema, K., Ansari, A., Petillo, D., Snider, J., Kahnoski, R., Anema, J., Craig, D., Carpten, J., Teh, B.-T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3227 · Cited by 159
Nrf1 Is Targeted to the Endoplasmic Reticulum Membrane by an N-terminal Transmembrane Domain
Wang, W., & Chan, J. Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602802200 · Cited by 158
Osburn, W. O., Yates, M. S., Dolan, P. D., Chen, S., Liby, K. T., Sporn, M. B., Taguchi, K., Yamamoto, M. P., & Kensler, T. W. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn079 · Cited by 158
Blank, V. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.074 · Cited by 154
Fujii, S., Sawa, T., Ihara, H., Tong, K. I., Ida, T., Okamoto, T., Ahmed, K. A., Ishima, Y., Motohashi, H., Yamamoto, M. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145441 · Cited by 152
Blake, D. J., Singh, A., Kombairaju, P., Malhotra, D., Mariani, T. J., Tuder, R. M., Gabrielson, E. W., & Biswal, S. S. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0054oc · Cited by 151
Takeda, K., Komuro, Y., Hayakawa, T., Oguchi, H., Ishida, Y., Murakami, S., Noguchi, T., Kinoshita, H., Sekine, Y., Iemura, S.-I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901823106 · Cited by 147
Sanderson, L. M., Boekschoten, M. V., Desvergne, B., Müller, M. M., & Kersten, S. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.00127.2009 · Cited by 147
Kelly, V. P., Ellis, E. M., Manson, M. M., Chanas, S. A., Moffat, G. J., McLeod, R., Judah, D. J., Neal, G. E., & Hayes, J. D. (2000) · PubMed · Cited by 147
Self-citationSoriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J. A., Baxter, P. S., Hayes, J. D., & Hardingham, G. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05648.x · Cited by 146
Self-citationReddy, N. M., Kleeberger, S. R., Bream, J. H., Fallon, P. G., Kensler, T. W., Yamamoto, M. P., & Reddy, S. P. (2008) · Oncogene · doi:10.1038/onc.2008.188 · Cited by 144
Kwon, J., Shatynski, K. E., Chen, H., Morand, S. C., Deken, X. D., Miot, F., Leto, T. L., & Williams, M. S. (2010) · Science Signaling · doi:10.1126/scisignal.2000976 · Cited by 143
Subcellular localization and cytoplasmic complex status of endogenous Keap1
Watai, Y., Kobayashi, A., Nagase, H., Mizukami, M., McEvoy, J. D., Singer, J. D., Itoh, K., & Yamamoto, M. P. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01118.x · Cited by 141
Rajasekaran, N. S., Varadharaj, S., Khanderao, G. D., Davidson, C. J., Kannan, S., Firpo, M. A., Zweier, J. L., & Benjamin, I. J. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3587 · Cited by 141
Innamorato, N. G., Jaźwa, A., Rojo, A. I., García, C., Fernández‐Ruíz, J., Grochot‐Przeczek, A., Stachurska, A., Józkowicz, A., Dulak, J., & Cuadrado, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011838 · Cited by 141
Cui, W., Bai, Y., Miao, X., Luo, P., Chen, Q., Tan, Y., Rane, M. J., Miao, L., & Cai, L. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/821936 · Cited by 141
mTORC2 in the center of cancer metabolic reprogramming
Masui, K., Cavenee, W. K., & Mischel, P. S. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.04.002 · Cited by 140
Niso‐Santano, M., González‐Polo, R. A., Pedro, J. M. B., Gómez‐Sánchez, R., Lastres‐Becker, I., Ortiz‐Ortiz, M. A., Soler, G., Morán, J. M., Cuadrado, A., & Fuentes, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.024 · Cited by 138
Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression
Jeong, W., Bae, S. H., Tolédano, M. B., & Rhee, S. G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.020 · Cited by 137
The PTEN/NRF2 Axis Promotes Human Carcinogenesis
Rojo, A. I., Rada, P., Mendiola, M., Ortega-Molina, A., Wojdyła, K., Rogowska-Wrzesińska, A., Hardisson, D., Serrano, M., & Cuadrado, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5843 · Cited by 135
Low reduction potential of Ero1α regulatory disulphides ensures tight control of substrate oxidation
Baker, K. M., Chakravarthi, S., Langton, K. P., Sheppard, A. M., Lu, H., & Bulleid, N. J. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.230 · Cited by 135
Inhibitory kappa B kinases as targets for pharmacological regulation
Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R. J., & Paul, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01608.x · Cited by 134
Glutathione and glutathione-dependent enzymes in cancer drug resistance
McLellan, L. I., & Wolf, C. R. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0083 · Cited by 133
Kim, Y., Yamaguchi, Y., Kondo, N., Masutani, H., & Yodoi, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206369 · Cited by 131
Tuning of Peroxiredoxin Catalysis for Various Physiological Roles
Perkins, A., Poole, L. B., & Karplus, P. A. (2014) · Biochemistry · doi:10.1021/bi5013222 · Cited by 131
Segmentally restricted, cephalic expression of a leucine zipper gene during Drosophila embryogenesis
Mohler, J., Vani, K., Leung, S., & Epstein, A. (1991) · Mechanisms of Development · doi:10.1016/0925-4773(91)90086-l · Cited by 129
Wang, X., Xing, G., Hong, B., Li, X., Zou, Y. S., Zhang, X., & Dong, M. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.08.004 · Cited by 128
Glutathione Peroxidase 1 Is Regulated by the c-Abl and Arg Tyrosine Kinases
Cao, C., Leng, Y., Huang, W., Liu, X., & Kufe, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305770200 · Cited by 128
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 128
Chemical Structures of Inducers of Nicotinamide Quinone Oxidoreductase 1 (NQO1)
Dinkova‐Kostova, A. T., Fahey, J. W., & Talalay, P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82023-8 · Cited by 126
Self-citationHawkes, H.-J. K., Karlenius, T., & Tonissen, K. F. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.013 · Cited by 126
Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species
Alvarez, A. R., Sandoval, P. C., Leal, N. R., Castro, P. U., & Kosik, K. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.007 · Cited by 125
Salsbury, F. R., Knutson, S. T., Poole, L. B., & Fetrow, J. S. (2008) · Protein Science · doi:10.1110/ps.073096508 · Cited by 125
Zhang, Y., Crouch, D. H., Yamamoto, M. P., & Hayes, J. D. (2006) · Biochemical Journal · doi:10.1042/bj20060725 · Cited by 124
Self-citationNrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans
Knatko, E. V., Ibbotson, S. H., Zhang, Y., Higgins, M., Fahey, J. W., Talalay, P., Dawe, R. S., Ferguson, J., Huang, J. T.-J., Clarke, R. G., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0362 · Cited by 124
Self-citationBarone, M. C., Sykiotis, G. P., & Bohmann, D. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007575 · Cited by 124
Ellis, E. M., Judah, D. J., Neal, G. E., & Hayes, J. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10350 · Cited by 123
Self-citationKovac, M. B., Navas, C., Horswell, S. D., Salm, M., Bardella, C., Rowan, A., Stares, M., Castro-Giner, F., Fisher, R. A., de Bruin, E. C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7336 · Cited by 123
Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski, E., Bontemps‐Gracz, M. M., & Piwkowska, A. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3421 · Cited by 123
Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype
Devling, T. W. P., LINDSAY, C. D., McLellan, L. I., McMahon, M. J., & Hayes, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501475102 · Cited by 122
Self-citationReductive Stress Linked to Small HSPs, G6PD, and Nrf2 Pathways in Heart Disease
Brewer, A. C., Mustafi, S. B., Murray, T. V., Rajasekaran, N. S., & Benjamin, I. J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4914 · Cited by 121
Williamson, T. P., Johnson, D. A., & Johnson, J. A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.015 · Cited by 121
Park, J., Mangal, D., Tacka, K. A., Quinn, A. M., Harvey, R. G., Blair, I. A., & Penning, T. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802776105 · Cited by 121
Self-citationOxidative Stress Induces Protein Kinase D Activation in Intact Cells
Waldron, R. T., & Rozengurt, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908959199 · Cited by 120
Palackal, N. T., Burczynski, M. E., Harvey, R. G., & Penning, T. M. (2001) · Biochemistry · doi:10.1021/bi010872t · Cited by 120
Self-citationEffects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome
Bondareva, A. A., Capecchi, M. R., Iverson, S. V., Li, Y., Lopez, N. I., Lucas, O., Merrill, G. F., Prigge, J. R., Siders, A. M., Wakamiya, M., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.026 · Cited by 119
Toki, T., Itoh, J., Kitazawa, J., Arai, K., Hatakeyama, K., Akasaka, J.-I., Igarashi, K., Nomura, N., Yokoyama, M., Yamamoto, M. P., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201024 · Cited by 116
Metabostemness: A New Cancer Hallmark
Menéndez, J. A., & Alarcón, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00262 · Cited by 116
Hayes, J. D., Judah, D. J., McLellan, L. I., Kerr, L. A., Peacock, S. D., & Neal, G. E. (1991) · Biochemical Journal · doi:10.1042/bj2790385 · Cited by 116
Self-citationmTOR pathway: A current, up-to-date mini-review (Review)
Zarogoulidis, P., Lampaki, S., Turner, J. F., Huang, H., Kakolyris, S., Syrigos, K., & Zarogoulidis, P. (2014) · Oncology Letters · doi:10.3892/ol.2014.2608 · Cited by 115
Identification of aldo-keto reductases as NRF2-target marker genes in human cells
Jung, K.-A., Choi, B.-H., Nam, C.-W., Song, M., Kim, S.-T., Lee, J. Y., & Kwak, M.-K. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.026 · Cited by 113
Dietary methionine can sustain cytosolic redox homeostasis in the mouse liver
Eriksson, S. E., Prigge, J. R., Talago, E. A., Arnér, E. S. J., & Schmidt, E. E. (2015) · Nature Communications · doi:10.1038/ncomms7479 · Cited by 112
Martin, H.-J., Breyer-Pfaff, U., Wsól, V., Venz, S., Block, S., & Maser, E. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007971 · Cited by 112
Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
Suvorova, E. S., Lucas, O., Weisend, C. M., Rollins, M. F., Merrill, G. F., Capecchi, M. R., & Schmidt, E. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006158 · Cited by 111
Targeting extracellular ROS signaling of tumor cells.
Bauer, G. (2014) · PubMed · Cited by 111
Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes
Martin, H.-J., & Maser, E. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.021 · Cited by 109
Cao, C., Leng, Y., Liu, X., Yi, Y., Li, P., & Kufe, D. W. (2003) · Biochemistry · doi:10.1021/bi035023f · Cited by 108
Aleksunes, L. M., Reisman, S. A., Yeager, R. L., Goedken, M. J., & Klaassen, C. D. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162271 · Cited by 106
An Exceptionally Potent Inducer of Cytoprotective Enzymes
Dinkova‐Kostova, A. T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W. D., Wang, X. J., David, E., Schiavoni, K. H., Finlayson, S. D., Mierke, D. F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163485 · Cited by 106
Self-citationNFE2L3 (NRF3): the Cinderella of the Cap‘n’Collar transcription factors
Chevillard, G., & Blank, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0747-x · Cited by 105
Chartoumpekis, D. V., & Kensler, T. W. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309020005 · Cited by 105
Primiano, T., Egner, P. A., Sutter, T. R., Kelloff, G. J., Roebuck, B. D., & Kensler, T. W. (1995) · PubMed · Cited by 105
Kaspar, J. W., & Jaiswal, A. K. (2010) · The FASEB Journal · doi:10.1096/fj.10-171553 · Cited by 101
Cited by
Sorted by citations
Transcriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,280
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,510
Self-citationNrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Davalli, P., Mitic, T., Caporali, A., Lauriola, A., & D’Arca, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3565127 · Cited by 1,059
Metadata
- Authors
- Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D.
- Affiliations
- University of Dundee (GB)
- AstraZeneca (United Kingdom) (GB)
- University of Pennsylvania (US)
- Corresponding author
- Hayes, John D.
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 88
- Issue
- Pt B
- Pages
- 108-146
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC4659505
- OpenAlex
- W1421415727
- Cited by
- 837
- References
- 514
- Citations by year
- 2026: 56 · 2025: 54 · 2024: 65 · 2023: 89 · 2022: 90 · 2021: 92 · 2020: 103 · 2019: 88 · 2018: 72 · 2017: 75 · 2016: 45 · 2015: 7
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Cancer Research UK (C4909/A13786)
- MRC (MR/J001465/1)
- MRC ITTP (1313992)
- BBSRC Industrial CASE (BB/L01405X/1)
- BBSRC (BB/L01923X/1, P30-ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2, redox stress, Keap1, mTORC1, p62/sequestosome 1, nutrient sensing, energy status, reactive oxygen species, xenobiotic metabolism, drug resistance, multidrug resistance, glutathione, thioredoxin, antioxidant defense, degenerative diseases
- MeSH terms
- Animals, Humans, Oxidation-Reduction, Signal Transduction, Oxidative Stress, NF-E2-Related Factor 2, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review